Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
106,498,737
-
Share change
-
-6,215,904
-
Total reported value
-
$193,856,679
-
Put/Call ratio
-
7%
-
Price per share
-
$1.82
-
Number of holders
-
156
-
Value change
-
-$20,125,101
-
Number of buys
-
86
-
Number of sells
-
50
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q3 2021
As of 30 Sep 2021,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
106,498,737 shares.
The largest 10 holders included
BlackRock Inc., MSD Partners, L.P., DISCOVERY CAPITAL MANAGEMENT, LLC / CT, VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
156
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.